Biotoxtech Company Limited operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotoxtech Company Limited with three other
pharmaceutical manufacturers in Asia:
Guangzhou Boji Medical & Biotechnological Co Ltd
sales of 172.04 million Chinese Renmimbi [US$24.29 million]
of which 61%
was Clinical research service),
Genetics Generation Advancement Corp
(381.66 million Taiwanese Dollars [US$12.46 million]
Ina Research Incorporation
based in Japan
(2.43 billion Japanese Yen [US$22.29 million]
During the year ended December of 2018, sales at
Biotoxtech Company Limited were 32.58 billion Korean Won (US$27.53 million).
increase of 27.4%
versus 2017, when the company's sales were 25.56 billion Korean Won.
This was the fourth straight year of sales growth at Biotoxtech Company Limited.